FDA NDC Directory · JSON-LD · Markdown

OXTELLAR XR

NDC 17772-121 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameOXCARBAZEPINE
Labeler / ManufacturerSupernus Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA202810
Dosage form / routeTABLET · ORAL
Active ingredientsOXCARBAZEPINE (150 mg/1)
Marketing started20130117
Package count3

External sources

Source: openFDA. Public-domain (CC0).